{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:14:02Z","timestamp":1783700042364,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1874\/22"],"award-info":[{"award-number":["1874\/22"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001658","name":"Minerva Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001658","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss Society Institute for Cancer Prevention Research"},{"DOI":"10.13039\/501100016982","name":"Rising Tide Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006544","name":"Ministry of Health, State of Israel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016267","name":"Perlman Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016267","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Weizmann Institute of Science"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Magn Reson Mater Phy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the utility of Deuterium Metabolic Imaging (DMI) as a tool for monitoring disease progression and assessing the therapeutic efficacy of cyclophosphamide in pancreatic ductal adenocarcinoma (PDAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study utilized C57BL mice implanted with a PDAC model, and separated into two experimental groups: One cohort served as an untreated control, while the second was treated with the chemotherapeutic agent cyclophosphamide (CP). Metabolic mapping for the two cohorts was performed over the course of weeks using 2H MRSI at 15.2T, tracking the metabolic pathway of deuterated glucose as it converts by the PDAC into lactate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CP administration led to a significant reduction in tumor growth and improved survival rates compared to the control group. Tumor growth rates for the untreated, control group, showed a strong inverse correlation for glucose\u2019s uptake and a strong direct correlation with the glucose-to-lactate conversion rates as seen by DMI. CP treatment disrupted both these correlations: Post-treatment, tumor growth rates became statistically uncorrelated with either glucose consumption or lactate production which, when normalized for tumor size, remained relatively constant during the treatment period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study demonstrates that CP treatment fundamentally alters the metabolic kinetics of glucose in PDAC tumors, inducing disruptions in metabolic correlations that may serve for distinguishing therapeutic success from failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10334-026-01340-z","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:55:47Z","timestamp":1775490947000},"page":"417-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the treatment of pancreatic ductal adenocarcinoma by deuterium metabolic imaging: a preclinical study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5898-1153","authenticated-orcid":false,"given":"Elton T.","family":"Montrazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Kovalevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Agemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avigdor","family":"Scherz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-3521","authenticated-orcid":false,"given":"Lucio","family":"Frydman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"1340_CR1","unstructured":"https:\/\/www.worldlifeexpectancy.com\/cause-of-death\/pancreas-cancer\/by-country\/"},{"key":"1340_CR2","unstructured":"Wallis C. https:\/\/www.scientificamerican.com\/article\/why-pancreatic-cancer-is-on-the-rise\/."},{"key":"1340_CR3","unstructured":"Cancer.org. https:\/\/www.cancer.org\/cancer\/pancreatic-cancer\/about\/key-statistics.html. 2021."},{"issue":"1","key":"1340_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329. https:\/\/doi.org\/10.3322\/caac.21208","journal-title":"CA Cancer J Clin"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejrad.2017.04.009","volume":"92","author":"J Toft","year":"2017","unstructured":"Toft J, Hadden WJ, Laurence JM, Lam V, Yuen L, Janssen A, Pleass H (2017) Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy. Eur J Radiol 92:17\u201323. https:\/\/doi.org\/10.1016\/j.ejrad.2017.04.009. (Epub 2017 Apr 24. PMID: 28624015.)","journal-title":"Eur J Radiol"},{"issue":"3","key":"1340_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.mric.2018.03.004","volume":"26","author":"P Jha","year":"2018","unstructured":"Jha P, Yeh BM, Zagoria R, Collisson E, Wang ZJ (2018) The role of MR imaging in pancreatic cancer. Magn Reson Imaging Clin N Am 26(3):363\u2013373. https:\/\/doi.org\/10.1016\/j.mric.2018.03.004. (Epub 2018 Jun 8. PMID: 30376975.)","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"11","key":"1340_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1177\/0284185120907246","volume":"61","author":"R Que","year":"2020","unstructured":"Que R, Chen Y, Tao Z, Ge B, Li M, Fu Z, Li Y (2020) Diffusion-weighted MRI versus FDG-PET\/CT for diagnosing pancreatic cancer: An indirect comparison meta-analysis. Acta Radiol 61(11):1473\u20131483. https:\/\/doi.org\/10.1177\/0284185120907246. (Epub 2020 Mar 8. PMID: 32148066.)","journal-title":"Acta Radiol"},{"issue":"2","key":"1340_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/17474124.2017.1271323","volume":"11","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Chen S, Zeng L, Chen Y, Lian G, Qian C, Li J, Xie R, Huang KH (2017) New developments in the early diagnosis of pancreatic cancer. Expert Rev Gastroenterol Hepatol 11(2):149\u2013156. https:\/\/doi.org\/10.1080\/17474124.2017.1271323. (Epub 2016 Dec 20. PMID: 27937041.)","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"1340_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13046-020-01765-x","volume":"39","author":"L Cao","year":"2020","unstructured":"Cao L, Wu J, Qu X, Sheng J, Cui M, Liu S, Huang X, Xiang Y, Li B, Zhang X, Cui R (2020) Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: Causes, characteristics and clinical applications. J Exp Clin Cancer Res 39(1):267. https:\/\/doi.org\/10.1186\/s13046-020-01765-x. (PMID: 33256814; PMCID: PMC7708116.)","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1340_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/gutjnl-2015-310114","volume":"65","author":"EM Serrao","year":"2016","unstructured":"Serrao EM, Kettunen MI, Rodrigues TB, Dzien P, Wright AJ, Gopinathan A, Gallagher FA, Lewis DY, Frese KK, Almeida J, Howat WJ, Tuveson DA, Brindle KM (2016) MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model. Gut 65(3):465\u2013475. https:\/\/doi.org\/10.1136\/gutjnl-2015-310114","journal-title":"Gut"},{"issue":"10","key":"1340_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103722","volume":"21","author":"P Dutta","year":"2020","unstructured":"Dutta P, Pando SC, Mascaro M, Riquelme E, Zoltan M, Zacharias NM, Gammon ST, Piwnica-Worms D, Pagel MD, Sen S, Maitra A, Shams S, McAllister F, Bhattacharya PK (2020) Early detection of pancreatic intraepithelial neoplasias (PanINs) in transgenic mouse model by hyperpolarized 13C metabolic magnetic resonance spectroscopy. Int J Mol Sci 21(10):3722. https:\/\/doi.org\/10.3390\/ijms21103722. (PMID: 32466260; PMCID: PMC7279395.)","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1340_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/jmri.26888","volume":"51","author":"H St\u00f8dkilde-J\u00f8rgensen","year":"2020","unstructured":"St\u00f8dkilde-J\u00f8rgensen H, Laustsen C, Hansen ESS, Schulte R, Ardenkjaer-Larsen JH, Comment A, Fr\u00f8kiaer J, Ringgaard S, Bertelsen LB, Ladekarl M, Weber B (2020) Pilot study experiences with hyperpolarized [1-13C]pyruvate MRI in pancreatic cancer patients. J Magn Reson Imaging 51(3):961\u2013963. https:\/\/doi.org\/10.1002\/jmri.26888. (Epub 2019 Aug 1. PMID: 31368215.)","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"1340_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4446","volume":"34","author":"RP Martinho","year":"2021","unstructured":"Martinho RP, Bao Q, Markovic S, Preise D, Sasson K, Agemy L, Scherz A, Frydman L (2021) Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized 13 C MRSI, 1 H diffusivity and 1 H T1 MRI. NMR Biomed 34(2):e4446. https:\/\/doi.org\/10.1002\/nbm.4446","journal-title":"NMR Biomed"},{"issue":"46","key":"1340_CR14","doi-asserted-by":"publisher","first-page":"31624","DOI":"10.1021\/jacs.4c09572","volume":"146","author":"H Allouche-Arnon","year":"2024","unstructured":"Allouche-Arnon H, Montrazi ET, Subramani B, Fisler M, Spigel I, Frydman L, Mehlman T, Brandis A, Harris T, Bar-Shir A (2024) A genetically engineered reporter system designed for 2H-MRI allows quantitative in vivo mapping of transgene expression. J Am Chem Soc 146(46):31624\u201331632. https:\/\/doi.org\/10.1021\/jacs.4c09572. (Nov 20;)","journal-title":"J Am Chem Soc"},{"issue":"5","key":"1340_CR15","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1021\/acs.nanolett.4c03036","volume":"25","author":"LM Fries","year":"2025","unstructured":"Fries LM, Montrazi ET, Allouche-Arnon H, Opazo F, Bar-Shir A, Frydman L, Gl\u00f6ggler S (2025) Deuterated nanopolymers for renal and lymphatic imaging via quantitative deuterium MRI. Nano Lett 25(5):1758\u20131764. https:\/\/doi.org\/10.1021\/acs.nanolett.4c03036. (Feb 5;)","journal-title":"Nano Lett"},{"issue":"5","key":"1340_CR16","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/mrm.28906","volume":"86","author":"DC Peters","year":"2021","unstructured":"Peters DC, Markovic S, Bao Q, Preise D, Sasson K, Agemy L, Scherz A, Frydman L (2021) Improving deuterium metabolic imaging (DMI) signal-to-noise ratio by spectroscopic multi-echo bSSFP: A pancreatic cancer investigation. Magn Reson Med 86(5):2604\u20132617. https:\/\/doi.org\/10.1002\/mrm.28906. (Epub 2021 Jun 30. PMID: 34196041.)","journal-title":"Magn Reson Med"},{"issue":"11","key":"1340_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4995","volume":"36","author":"ET Montrazi","year":"2023","unstructured":"Montrazi ET, Bao Q, Martinho RP, Peters DC, Harris T, Sasson K, Agemy L, Scherz A, Frydman L (2023) Deuterium imaging of the Warburg effect at sub-millimolar concentrations by joint processing of the kinetic and spectral dimensions. NMR Biomed 36(11):e4995. https:\/\/doi.org\/10.1002\/nbm.4995","journal-title":"NMR Biomed"},{"issue":"1","key":"1340_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47301-7","volume":"13","author":"ET Montrazi","year":"2023","unstructured":"Montrazi ET, Sasson K, Agemy L, Peters DC, Brenner O, Scherz A, Frydman L (2023) High-sensitivity deuterium metabolic MRI differentiates acute pancreatitis from pancreatic cancers in murine models. Sci Rep 13(1):19998. https:\/\/doi.org\/10.1038\/s41598-023-47301-7. (PMID: 37968574; PMCID: PMC10652017.)","journal-title":"Sci Rep"},{"issue":"11","key":"1340_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm8600","volume":"10","author":"ET Montrazi","year":"2024","unstructured":"Montrazi ET, Sasson K, Agemy L, Scherz A, Frydman L (2024) Molecular imaging of tumor metabolism: insight from pyruvate- and glucose-based deuterium MRI studies. Sci Adv 10(11):eadm8600. https:\/\/doi.org\/10.1126\/sciadv.adm8600. (Mar 15;)","journal-title":"Sci Adv"},{"issue":"11","key":"1340_CR20","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1177\/0271678X17706444","volume":"37","author":"M Lu","year":"2017","unstructured":"Lu M, Zhu XH, Zhang Y, Mateescu G, Chen W (2017) Quantitative assessment of brain glucose metabolic rates using in vivo deuterium magnetic resonance spectroscopy. J Cereb Blood Flow Metab 37(11):3518\u20133530. https:\/\/doi.org\/10.1177\/0271678X17706444. (Epub 2017 May 15. PMID: 28503999; PMCID: PMC5669347)","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"1340_CR21","doi-asserted-by":"publisher","first-page":"eaat7314","DOI":"10.1126\/sciadv.aat7314","volume":"4","author":"HM De Feyter","year":"2018","unstructured":"De Feyter HM, Behar KL, Corbin ZA, Fulbright RK, Brown PB, McIntyre S, Nixon TW, Rothman DL, de Graaf RA (2018) Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Sci Adv 4(8):eaat7314. https:\/\/doi.org\/10.1126\/sciadv.aat7314. (PMID: 30140744; PMCID: PMC6105304)","journal-title":"Sci Adv"},{"issue":"3","key":"1340_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4235","volume":"33","author":"RA de Graaf","year":"2020","unstructured":"de Graaf RA, Hendriks AD, Klomp DWJ, Kumaragamage C, Welting D, de Arteaga Castro CS, Brown PB, McIntyre S, Nixon TW, Prompers JJ, De Feyter HM (2020) On the magnetic field dependence of deuterium metabolic imaging. NMR Biomed 33(3):e4235. https:\/\/doi.org\/10.1002\/nbm.4235. (Epub 2019 Dec 26. PMID: 31879985; PMCID: PMC7141779)","journal-title":"NMR Biomed"},{"issue":"2","key":"1340_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.2019191242","volume":"294","author":"F Kreis","year":"2020","unstructured":"Kreis F, Wright AJ, Hesse F, Fala M, Hu DE, Brindle KM (2020) Measuring tumor glycolytic flux in vivo by using fast deuterium MRI. Radiology 294(2):289\u2013296. https:\/\/doi.org\/10.1148\/radiol.2019191242. (Epub 2019 Dec 10. PMID: 31821119.)","journal-title":"Radiology"},{"issue":"6","key":"1340_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252935","volume":"16","author":"B Hartmann","year":"2021","unstructured":"Hartmann B, M\u00fcller M, Seyler L, B\u00e4uerle T, Wilferth T, Avdievitch N, Ruhm L, Henning A, Lesiv A, Ivashkin P, Uder M, Nagel AM (2021) Feasibility of deuterium magnetic resonance spectroscopy of 3-O-Methylglucose at 7 Tesla. PLoS ONE 16(6):e0252935. https:\/\/doi.org\/10.1371\/journal.pone.0252935","journal-title":"PLoS ONE"},{"key":"1340_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmr.2021.106932","volume":"326","author":"HM De Feyter","year":"2021","unstructured":"De Feyter HM, de Graaf RA (2021) Deuterium metabolic imaging - back to the future. J Magn Reson 326:106932. https:\/\/doi.org\/10.1016\/j.jmr.2021.106932","journal-title":"J Magn Reson"},{"issue":"16","key":"1340_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164034","volume":"13","author":"A Veltien","year":"2021","unstructured":"Veltien A, van Asten J, Ravichandran N, de Graaf RA, De Feyter HM, Oosterwijk E, Heerschap A (2021) Simultaneous recording of the uptake and conversion of glucose and choline in tumors by Deuterium Metabolic Imaging. Cancers (Basel) 13(16):4034. https:\/\/doi.org\/10.3390\/cancers13164034","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1340_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/mrm.29196","volume":"88","author":"Y Liu","year":"2022","unstructured":"Liu Y, De Feyter HM, Fulbright RK, McIntyre S, Nixon TW, de Graaf RA (2022) Interleaved fluid-attenuated inversion recovery (FLAIR) MRI and deuterium metabolic imaging (DMI) on human brain in vivo. Magn Reson Med 88(1):28\u201337. https:\/\/doi.org\/10.1002\/mrm.29196. (Epub 2022 Feb 28. PMID: 35225375; PMCID: PMC9924309)","journal-title":"Magn Reson Med"},{"issue":"277","key":"1340_CR28","doi-asserted-by":"publisher","first-page":"120250","DOI":"10.1016\/j.neuroimage.2023.120250","volume":"15","author":"F Niess","year":"2023","unstructured":"Niess F, Strasser B, Hingerl L, Niess E, Motyka S, Hangel G, Kr\u0161\u0161\u00e1k M, Gruber S, Spurny-Dworak B, Trattnig S, Scherer T, Lanzenberger R, Bogner W (2023) Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct (2H) and indirect (1H) detection of deuterium labeled compounds at 7T and clinical 3T. Neuroimage 15(277):120250. https:\/\/doi.org\/10.1016\/j.neuroimage.2023.120250. (Epub 2023 Jul 4. PMID: 37414233; PMCID: PMC11019874)","journal-title":"Neuroimage"},{"issue":"24","key":"1340_CR29","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1158\/1078-0432.CCR-23-1635","volume":"29","author":"H Asano","year":"2023","unstructured":"Asano H, Elhelaly AE, Hyodo F, Iwasaki R, Noda Y, Kato H, Ichihashi K, Tomita H, Murata M, Mori T, Matsuo M (2023) Deuterium Magnetic Resonance Imaging using deuterated water-induced 2H-tissue labeling allows monitoring cancer treatment at clinical field strength. Clin Cancer Res 29(24):5173\u20135182. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1635","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1340_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4926","volume":"36","author":"A Gursan","year":"2023","unstructured":"Gursan A, Hendriks AD, Welting D, de Jong PA, Klomp DWJ, Prompers JJ (2023) Deuterium body array for the simultaneous measurement of hepatic and renal glucose metabolism and gastric emptying with dynamic 3D deuterium metabolic imaging at 7 T. NMR Biomed 36(8):e4926. https:\/\/doi.org\/10.1002\/nbm.4926. (Epub 2023 Apr 2. PMID: 36929629)","journal-title":"NMR Biomed"},{"issue":"12","key":"1340_CR31","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1109\/TMI.2021.3101149","volume":"40","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao Y, Guo R, Wang T, Zhang Y, Chrostek M, Low WC, Zhu XH, Liang ZP, Chen W (2021) Machine learning-enabled high-resolution dynamic deuterium MR spectroscopic imaging. IEEE Trans Med Imaging 40(12):3879\u20133890. https:\/\/doi.org\/10.1109\/TMI.2021.3101149. (Epub 2021 Nov 30. PMID: 34319872; PMCID: PMC8675063.)","journal-title":"IEEE Trans Med Imaging"},{"issue":"3","key":"1340_CR32","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/jmri.29532","volume":"61","author":"N Ahmadian","year":"2025","unstructured":"Ahmadian N, Konig MM, Otto S, Tesselaar K, van Eijsden P, Gosselink M, Gursan A, Klomp DW, Prompers JJ, Wiegers EC (2025) Human Brain Deuterium Metabolic Imaging at 7 T: Impact of Different [6,6\u2019-2H2]Glucose Doses. J Magn Reson Imaging 61(3):1170\u20131178. https:\/\/doi.org\/10.1002\/jmri.29532. (Epub 2024 Jul 26. PMID: 39058248; PMCID: PMC11803682)","journal-title":"J Magn Reson Imaging"},{"key":"1340_CR33","doi-asserted-by":"publisher","first-page":"25321580","DOI":"10.1101\/2025.02.06.25321580","volume":"2025.02.06","author":"S Frese","year":"2025","unstructured":"Frese S, Strasser B, Hingerl L, Montrazi E, Frydman L, Motyka S, Bader V, Duguid A, Osburg A, Krssak M, Lanzenberger R, Scherer T, Bogner W, Niess F (2025) Balanced steady state free precession enables high-resolution dynamic 3D Deuterium Metabolic Imaging of the human brain at 7T. medRxiv [Preprint] 2025.02.06:25321580. https:\/\/doi.org\/10.1101\/2025.02.06.25321580. (Update in: Invest Radiol. 2025 Apr 25. 10.1097\/RLI.0000000000001196. PMID: 39974047; PMCID: PMC11838661)","journal-title":"medRxiv [Preprint]"},{"issue":"6","key":"1340_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.eururo.2017.07.022","volume":"72","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, Vigneron DB, Kurhanewicz J (2017) Hyperpolarized 1-[13C]-pyruvate magnetic resonance imaging detects an early metabolic response to androgen ablation therapy in prostate cancer. Eur Urol 72(6):1028\u20131029. https:\/\/doi.org\/10.1016\/j.eururo.2017.07.022","journal-title":"Eur Urol"},{"issue":"4","key":"1340_CR35","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2020200017","volume":"2","author":"R Woitek","year":"2020","unstructured":"Woitek R, McLean MA, Gill AB et al (2020) Hyperpolarized 13C MRI of tumor metabolism demonstrates early metabolic response to neoadjuvant chemotherapy in breast cancer. Radiology Imaging Cancer. 2(4):e200017","journal-title":"Radiology Imaging Cancer."},{"key":"1340_CR36","first-page":"130","volume":"23","author":"KL Granlund","year":"2020","unstructured":"Granlund KL, Tee SS, Vargas HA et al (2020) Hyperpolarized 13C-pyruvate MRI detects real-time metabolic response in metastatic prostate cancer. Prostate Cancer Prostatic Dis 23:130\u2013137","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1340_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.100570.3","volume":"13","author":"RV Sim\u00f5es","year":"2024","unstructured":"Sim\u00f5es RV, Henriques RN, Olesen JL et al (2024) Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics. Elife 13:e100570","journal-title":"Elife"},{"issue":"12","key":"1340_CR38","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-23-2552","volume":"84","author":"JCM Low","year":"2024","unstructured":"Low JCM, Cao J, Henriques RN et al (2024) Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy. Cancer Res 84(12):1996\u20132008. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2552","journal-title":"Cancer Res"},{"issue":"13","key":"1340_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr0568","volume":"11","author":"MC Chang","year":"2025","unstructured":"Chang MC, Malut VR, Mahar R, Rushin A, McLeod MA, Pierre GL, Malut IR, Staklinski SJ, Glanz ME, Ragavan M, Sharma G, Madheswaran M, Badar A, Rao AD, Law BK, Kilberg MS, Collins JHP, Kodibagkar VD, Bankson JA, DeBerardinis RJ, Merritt ME (2025) Assessing cancer therapeutic efficacy in vivo using [2H7]glucose Deuterium metabolic imaging. Sci Adv 11(13):eadr0568. https:\/\/doi.org\/10.1126\/sciadv.adr0568. (Epub 2025 Mar 26. PMID: 40138413; PMCID: PMC11939044)","journal-title":"Sci Adv"},{"issue":"11","key":"1340_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6(11):638\u2013647. https:\/\/doi.org\/10.1038\/nrclinonc.2009.146","journal-title":"Nat Rev Clin Oncol"},{"key":"1340_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/267539","volume":"2011","author":"S Koido","year":"2011","unstructured":"Koido S, Homma S, Takahara A, Namiki Y, Tsukinaga S, Mitobe J, Odahara S, Yukawa T, Matsudaira H, Nagatsuma K, Uchiyama K, Satoh K, Ito M, Komita H, Arakawa H, Ohkusa T, Gong J, Tajiri H (2011) Current immunotherapeutic approaches in pancreatic cancer. Clin Dev Immunol 2011:267539. https:\/\/doi.org\/10.1155\/2011\/267539. (Epub 2011 Sep 14. PMID: 21922022; PMCID: PMC3172984)","journal-title":"Clin Dev Immunol"},{"key":"1340_CR42","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.csbj.2019.03.016","volume":"17","author":"J Li","year":"2019","unstructured":"Li J, Qian W, Qin T, Xiao Y, Cheng L, Cao J, Chen X, Ma Q, Wu Z (2019) Mouse-derived allografts: A complementary model to the KPC Mice on researching pancreatic cancer in vivo. Comput Struct Biotechnol J 17:498\u2013506. https:\/\/doi.org\/10.1016\/j.csbj.2019.03.016","journal-title":"Comput Struct Biotechnol J"},{"issue":"9","key":"1340_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4569","volume":"34","author":"S Markovic","year":"2021","unstructured":"Markovic S, Roussel T, Agemy L, Sasson K, Preise D, Scherz A, Frydman L (2021) Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models. NMR Biomed 34(9):e4569. https:\/\/doi.org\/10.1002\/nbm.4569. (Epub 2021 Jun 16. PMID: 34137085)","journal-title":"NMR Biomed"},{"issue":"4","key":"1340_CR44","doi-asserted-by":"publisher","first-page":"E623","DOI":"10.1152\/ajpendo.00050.2002","volume":"283","author":"D Rivenzon-Segal","year":"2002","unstructured":"Rivenzon-Segal D, Margalit R, Degani H (2002) Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS. Am J Physiol Endocrinol Metab 283(4):E623\u2013E630. https:\/\/doi.org\/10.1152\/ajpendo.00050.2002","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Magnetic Resonance Materials in Physics, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-026-01340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10334-026-01340-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-026-01340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:29:33Z","timestamp":1783697373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10334-026-01340-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s10334-026-01340-z","relation":{},"ISSN":["1352-8661"],"issn-type":[{"value":"1352-8661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}